SCM
ABBV icon

Sage Capital Management’s AbbVie ABBV Stock Holding History

Sage Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$879K Buy
3,493
+8
+0.2% +$1.72K 0.34% 64
2026
Q1 		$758K Buy
3,485
+8
+0.2% +$1.77K 0.36% 63
2025
Q4 		$795K Buy
3,477
+6
+0.2% +$1.37K 0.37% 62
2025
Q3 		$804K Buy
3,471
+7
+0.2% +$1.43K 0.36% 63
2025
Q2 		$643K Buy
3,464
+9
+0.3% +$1.67K 0.31% 68
2025
Q1 		$724K Buy
3,455
+8
+0.2% +$1.55K 0.39% 60
2024
Q4 		$613K Buy
3,447
+58
+2% +$10.7K 0.31% 73
2024
Q3 		$669K Buy
3,389
+7
+0.2% +$1.31K 0.32% 69
2024
Q2 		$580K Buy
3,382
+9
+0.3% +$1.49K 0.3% 75
2024
Q1 		$614K Buy
3,373
+7
+0.2% +$1.21K 0.33% 73
2023
Q4 		$522K Buy
+3,366
New +$491K 0.31% 77

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Sage Capital Management's ABBV Position: Q2 2026 in Review

Sage Capital Management increased its AbbVie (ABBV) stake by 0.23% in Q2 2026, buying an estimated $1.72K and bringing the position to 3,493 shares worth $879K. The position accounts for 0.34% of the portfolio, ranked #64.

Sage Capital Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sage Capital Management held 3,493 shares of AbbVie worth $879K as of Q2 2026.
  • Sage Capital Management bought 8 AbbVie shares in Q2 2026, an estimated $1.72K.
  • AbbVie made up 0.34% of Sage Capital Management's portfolio in Q2 2026, its #64 holding.
  • Sage Capital Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 1,601 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sage Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.